Clarity Medical: Co-CEO Chris Hui to Step Down in April 2026, Remain Senior Advisor Until June 2026

Bulletin Express
05/15

Clarity Medical Group Holding Limited announced the resignation of Mr. Hui Yung Chris from his roles as Co-Chief Executive Officer and authorised process agent, effective 30 April 2026. The departure, made under Rule 13.51(2) of the Hong Kong Listing Rules, is attributed to Mr. Hui’s intention to devote more time to personal and business commitments.

Following his resignation, Mr. Hui will continue to support the company as a senior advisor until 30 June 2026. He confirmed no disagreements with the board and stated that no additional matters require shareholder attention.

The board expressed appreciation for Mr. Hui’s contributions during his tenure. Current executive leadership will remain under Executive Director and CEO Mr. Jiang Bo. The board composition at the announcement date comprises one executive director, four non-executive directors and four independent non-executive directors.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10